
Breaking Down the FDA’s Draft Guidance on Artificial Intelligence-Enabled Device Software Functions
The FDA’s latest draft guidance addresses how AI-enabled device software should be developed, monitored, and updated. From lifecycle planning to model transparency and cybersecurity, here’s what healthtech and medtech teams need to know to stay compliant and innovative in 2025.